TSX runs higher on rate cut expectations
Investing.com - Vincerx Pharma reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that was inline with expectations.
Vincerx Pharma announced earnings per share of $-0.80 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.55 on revenue of $0.00.
Vincerx Pharma 's are down 53.92% and is trading at $0.93 , still down 93.30% from its 52 week high of $13.88 set on Friday, November 12, 2021.
Vincerx Pharma follows other major Healthcare sector earnings this month
Vincerx Pharma's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar